⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4185028 | 0.77 | — | — | |
| SCHEMBL1502286 | 0.77 | — | — | |
| SCHEMBL28128620 | 0.74 | — | — | |
| SCHEMBL16097216 | 0.74 | — | — | |
| Ammonia Solution, Strong SCHEMBL28053251 | 0.74 | — | — | |
| SCHEMBL27916416 | 0.72 | — | — | |
| SCHEMBL11664452 | 0.72 | TSHR (0.32) | — | |
| SCHEMBL982533 | 0.67 | — | — | |
| SCHEMBL27799340 | 0.67 | — | — | |
| Ethylene Glycol SCHEMBL9791694 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040214783-A1 | conjugates, fusion proteins or naked nucleic acids of superantigen (SAg) which produce an anti-tumor responses in transfected host cells (tumor cells, accessory cells or lymphocytes); cancer treatment | TERMAN DAVID S (US) | 2004-10-28 | — | — | US | disclosed |
| US-20030157113-A1 | Mammalian cell which inhibits cellular activation by receptors specific for lipid-based tumor associatiated antigens; anticancer agents | TERMAN DAVID S (US) | 2003-08-21 | — | — | US | disclosed |
| US-20020177551-A1 | Compositions and methods for treatment of neoplastic disease | TERMAN DAVID S (US) | 2002-11-28 | — | — | US | disclosed |